BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 17977429)

  • 21. A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors.
    Bokemeyer C; Köhrmann O; Tischler J; Weissbach L; Räth U; Haupt A; Schöffski P; Harstrick A; Schmoll HJ
    Ann Oncol; 1996 Dec; 7(10):1015-21. PubMed ID: 9037359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors.
    Horwich A; Dearnaley DP; Nicholls J; Jay G; Mason M; Harland S; Peckham MJ; Hendry WF
    J Clin Oncol; 1991 Jan; 9(1):62-9. PubMed ID: 1702147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Survival and quality of life of patients with testicular cancer].
    Lugagne Delpon PM; Petit M; Houlgatte A; Droz JP
    Ann Urol (Paris); 1998; 32(2):80-2. PubMed ID: 9599637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective study of carboplatin-based chemotherapy for pediatric germ cell tumors.
    Stern JW; Bunin N
    Med Pediatr Oncol; 2002 Sep; 39(3):163-7. PubMed ID: 12210444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-line chemotherapy of non-seminomatous germ cell tumors(NSGCTs).
    Pliarchopoulou K; Pectasides D
    Cancer Treat Rev; 2009 Nov; 35(7):563-9. PubMed ID: 19576697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy].
    Riedinger JM; Eche N; Chevreau C; Fargeot P
    Ann Biol Clin (Paris); 2008; 66(5):523-30. PubMed ID: 18957341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.
    Lorch A; Kollmannsberger C; Hartmann JT; Metzner B; Schmidt-Wolf IG; Berdel WE; Weissinger F; Schleicher J; Egerer G; Haas A; Schirren R; Beyer J; Bokemeyer C; Rick O;
    J Clin Oncol; 2007 Jul; 25(19):2778-84. PubMed ID: 17602082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Testicular malignant tumours. Efficacy of germ cell and sex cord tumours treatment protocol in Poland].
    Popadiuk S; Korzon M; Chybicka A; Szmyd K; Dzierzega M; Trelińska J; Kowalczyk JR; Wiśniewska-Slusarz H; Woźniak W; Bilska K; Wachowiak J; Konatkowska B; Wysocki M; Krawczuk-Rybak M; Czauderna P; Szumera M; Sznurkowska K; Renke J
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):811-7. PubMed ID: 17317912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
    Motzer RJ; Nichols CJ; Margolin KA; Bacik J; Richardson PG; Vogelzang NJ; Bajorin DF; Lara PN; Einhorn L; Mazumdar M; Bosl GJ
    J Clin Oncol; 2007 Jan; 25(3):247-56. PubMed ID: 17235042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The chemotherapy of disseminated testicular non-seminomatous germ cell tumors and the clinical research of the EORTC Genitourinary Group.
    Stoter G
    Prog Clin Biol Res; 1985; 203():437-47. PubMed ID: 2421335
    [No Abstract]   [Full Text] [Related]  

  • 31. [Combination chemotherapy with bleomycin, vincristine and methotrexate for stage I non-seminomatous germ cell testicular tumors].
    Fukui I; Yokokawa M; Wakui M; Washizuka M; Katoh M; Igarashi K; Takeuchi S; Gotoh S; Afuso H; Tachibana Y
    Hinyokika Kiyo; 1983 Feb; 29(2):191-8. PubMed ID: 6203379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose chemotherapy in nonseminomatous germ cell cancer.
    Kollmannsberger C; Beyer J; Bokemeyer C
    BJU Int; 2009 Nov; 104(9 Pt B):1398-403. PubMed ID: 19840020
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
    Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
    Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant chemotherapy for stage I non-seminomatous testicular cancer.
    Abratt RP; Pontin AR; Barnes RD; Reddi BV
    S Afr Med J; 1994 Sep; 84(9):605-7. PubMed ID: 7530863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study.
    Mardiak J; Sálek T; Sycová-Milá Z; Obertová J; Recková M; Mego M; Hlavatá Z; Brozmanová K; Risnyovzská Z; Svetlovská D; Koza I
    Neoplasma; 2007; 54(3):240-5. PubMed ID: 17447857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Medical treatment of metastatic germ cell cancers].
    Timsit MO; Lebret T; Lugagne PM; Méjean A
    Prog Urol; 2008 Nov; 18 Suppl 7():S376-81. PubMed ID: 19070818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy is of limited efficacy in the control of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell cancer.
    Kleinschmidt K; Dieckmann KP; Georgiew A; Loy V; Weissbach L
    Oncology; 2009; 77(1):33-9. PubMed ID: 19440001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens?
    Bokemeyer C
    J Clin Oncol; 2008 Apr; 26(11):1783-5. PubMed ID: 18398143
    [No Abstract]   [Full Text] [Related]  

  • 39. Failure of high-dose cyclophosphamide and etoposide combined with double-dose cisplatin and bone marrow support in patients with high-volume metastatic nonseminomatous germ-cell tumours: mature results of a randomised trial.
    Droz JP; Kramar A; Biron P; Pico JL; Kerbrat P; Pény J; Curé H; Chevreau C; Théodore C; Bouzy J; Culine S;
    Eur Urol; 2007 Mar; 51(3):739-46; discussion 747-8. PubMed ID: 17084512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Ma2 paraneoplastic encephalitis associated with testicular germ cell tumor treated by carboplatin, etoposide and bleomycin.
    Kimura M; Onozawa M; Fujisaki A; Arakawa T; Takeda K; Dalmau J; Hattori K
    Int J Urol; 2008 Oct; 15(10):942-3. PubMed ID: 19138287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.